Last reviewed · How we verify
NCT05653596: CHEERS
VR-based Intervention for Cognitive Restoration
NA trial testing Virtual reality-based cognitive intervention in Breast Cancer in 200 participants. Status unknown.
28 February 2025
Quick facts
| Lead sponsor | Chungnam National University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 200 |
| Start date | 10 December 2019 |
| Primary completion | 28 February 2025 |
| Estimated completion | 31 July 2025 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Virtual reality-based cognitive intervention
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Cognitive Dysfunction — all drugs for Cognitive Dysfunction →
- Virtual Reality — all drugs for Virtual Reality →
Sponsor
Chungnam National University
Who can join
Adults 19 to 64, female only, with Breast Cancer or Cognitive Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to test the efficacy of a nature-based cognitive intervention to restore cognitive function among women treated for breast cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05653596
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Chungnam National University trials
Trials by the same sponsor.
- NCT05629728 — Tai Chi for Improving Functions of Frail Older Adults · NA · recruiting
- NCT04734613 — Tai Chi for Behavioral Modification Among Individuals With Metabolic Syndrome · NA · completed
- NCT05629650 — Feasibility Study of Tai Chi for Cognitively Impaired Older Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05653596 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chungnam National University
- Last refreshed: 6 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05653596.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing